Chemed Corporation $CHE Shares Acquired by Hsbc Holdings PLC

Key Points

• Hsbc Holdings PLC increased its Chemed stake by 41.7% in the second quarter, bringing its holdings to 12,346 shares valued at approximately $5.7 million. Institutional investors and hedge funds collectively own 95.85% of CHE.
• Chemed reported quarterly EPS of $6.06, exceeding the $5.60 analyst consensus, while revenue rose 8.8% year over year to $673.25 million. The company issued fiscal 2026 EPS guidance of $25.00–$25.75.
• Analysts maintain a consensus “Hold” rating with a $530.75 target price, despite some upgrades and higher price targets. Chemed also raised its quarterly dividend to $0.70 per share, while insiders sold $2.8 million of stock over the past 90 days.

Hsbc Holdings PLC increased its holdings in shares of Chemed Corporation (NYSE:CHE - Free Report) by 41.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 12,346 shares of the company's stock after purchasing an additional 3,632 shares during the quarter. Hsbc Holdings PLC owned approximately 0.09% of Chemed worth $5,729,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CHE. Commonwealth Equity Services LLC raised its holdings in Chemed by 3.1% during the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company's stock worth $314,000 after purchasing an additional 22 shares in the last quarter. Cim LLC boosted its holdings in shares of Chemed by 1.1% in the 3rd quarter. Cim LLC now owns 2,139 shares of the company's stock valued at $958,000 after buying an additional 24 shares in the last quarter. Eukles Asset Management grew its position in shares of Chemed by 0.4% in the 4th quarter. Eukles Asset Management now owns 6,056 shares of the company's stock valued at $2,591,000 after buying an additional 25 shares during the last quarter. MassMutual Private Wealth & Trust FSB raised its stake in Chemed by 65.3% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company's stock worth $38,000 after acquiring an additional 32 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in Chemed by 9.4% in the first quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company's stock valued at $153,000 after acquiring an additional 35 shares during the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have issued reports on CHE shares. Royal Bank Of Canada upped their price objective on shares of Chemed from $436.00 to $548.00 and gave the company a "sector perform" rating in a research note on Thursday, July 30th. Weiss Ratings raised Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research report on Friday, July 17th. Oppenheimer raised their price target on Chemed from $500.00 to $590.00 and gave the stock an "outperform" rating in a research note on Friday, July 31st. Bank of America reiterated a "neutral" rating on shares of Chemed in a research note on Wednesday, July 29th. Finally, Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "strong-buy" rating in a research report on Saturday, August 1st. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $530.75.

Chemed Stock Performance

NYSE:CHE opened at $518.12 on Thursday. The firm has a market cap of $6.77 billion, a price-to-earnings ratio of 26.02, a price-to-earnings-growth ratio of 1.97 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $557.00. The firm's fifty day moving average price is $519.73 and its 200 day moving average price is $452.69.

Chemed (NYSE:CHE - Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts' consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.Chemed's quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the company earned $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, sell-side analysts expect that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th were paid a dividend of $0.70 per share. The ex-dividend date of this dividend was Monday, August 17th. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. This is an increase from Chemed's previous quarterly dividend of $0.60. Chemed's dividend payout ratio is 14.06%.

Insider Activity

In other Chemed news, EVP Spencer S. Lee sold 1,000 shares of Chemed stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $541.04, for a total value of $541,040.00. Following the completion of the sale, the executive vice president owned 13,912 shares in the company, valued at $7,526,948.48. The trade was a 6.71% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Patrick P. Grace sold 190 shares of the business's stock in a transaction on Friday, July 31st. The shares were sold at an average price of $532.00, for a total transaction of $101,080.00. Following the sale, the director directly owned 3,533 shares of the company's stock, valued at $1,879,556. This represents a 5.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 5,190 shares of company stock valued at $2,803,460 over the last 90 days. Insiders own 3.33% of the company's stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.